Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial.
暂无分享,去创建一个
Jefferson R. Wilson | S. Harkema | R. Grossman | B. Aarabi | M. Fehlings | J. Guest | R. Frankowski | Charles Tator | C. Shaffrey | K. Burau | J. Harrop | Elizabeth G Toups | Michele W Johnson | Elizabeth G. Toups | J. Wilson | Jefferson R. Wilson